Anthem aims to price notes due 2048 via three bookrunners, remarket $1.25 billion of 2028 notes

By Devika Patel

Knoxville, Tenn., Feb. 27 – Anthem, Inc. is offering notes due 2048, according to a 424B3 filing with the Securities and Exchange Commission.

In addition, selling noteholders will also sell $1.25 billion of notes due 2028 in a remarketing of the securities for 1.9% remarketable subordinated notes.

The new 2048 notes have a make-whole call until six months before maturity and then are callable at par.

Credit Suisse Securities (USA) LLC, Barclays and Morgan Stanley & Co. LLC are the bookrunners.

Proceeds will be used for working capital and for general corporate purposes, including debt repayment or stock repurchases.

Indianapolis-based Anthem is a health benefits company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.